Company / Net Income
OptimizeRx Corp Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$20.1M
FY2025
5-year range
-$20.1M / $378.1K
FY2021-FY2025
Trend
-14.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Net Income has declined for 3 consecutive years, from $378,079 in FY2022 to -$20M in FY2025.
Based on SEC 10-K filings.
-$20M in FY2025.
Declined from -$11M to -$20M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- OptimizeRx Corp's net income has declined for 3 consecutive years.
- In FY2025, net income decreased 14.5% year-over-year.
- Peak net income was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$20.1M | -14.5% |
| FY2024 | -$17.6M | -53.6% |
| FY2023 | -$11.4M | -3125.4% |
| FY2022 | $378.1K | +117.1% |
| FY2021 | -$2.2M | +29.8% |
| FY2020 | -$3.1M | -1488.4% |
| FY2019 | $226.3K | +110.8% |
| FY2018 | -$2.1M | -36.7% |
| FY2017 | -$1.5M | -158.6% |
| FY2016 | -$595.1K | +42.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026